(Q45216038)

10 December 2017

Assessment of serum flecainide trough levels in patients with tachyarrhythmia (English)

1 reference

10 December 2017

Masato Homma

1

1 reference

10 December 2017

Keisuke Kuga

2

1 reference

10 December 2017

Kosuke Doki

3

1 reference

10 December 2017

Kumi Katori

4

1 reference

10 December 2017

Iwao Yamaguchi

5

1 reference

10 December 2017

Kenji Sugibayashi

6

1 reference

10 December 2017

Yukinao Kohda

7

1 reference

10 December 2017

1 January 2005

1 reference

Journal of Pharmacy and Pharmacology

10 December 2017

1 reference

10 December 2017

57

1 reference

10 December 2017

1

1 reference

10 December 2017

47-51

1 reference

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

10 December 2017

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

Oral flecainide pharmacokinetics in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

High performance liquid chromatography for routine monitoring of serum flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

Pharmacodynamic variability of flecainide assessed by QRS changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

21 January 2018

Drug therapy. Flecainide

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

Pharmacokinetics of flecainide acetate in patients with severe renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357055128

21 January 2018

Identifiers

DOI

10.1211/0022357055128

1 reference

10 December 2017

1 reference